Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial
| Autor: | Wang, Huafeng *, Mao, Liping *, Yang, Min *, Qian, Pengxu *, Lu, Huan *, Tong, Hongyan, Xie, Wanzhuo, Zhou, De, Huang, Xin, Wang, Yungui, Xu, Gaixiang, Lu, Ying, Wei, Juying, Mai, Wenyuan, Ye, Xiujin, Meng, Haitao, Shen, Yaojia, Huang, Jian, Yu, Wenjuan, Sun, Jie, Sheng, Jianpeng, Yan, Xiaoyan, Jin, Jie, Zhu, Hong-Hu * |
|---|---|
| Zdroj: | In The Lancet Haematology June 2022 9(6):e415-e424 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|